当前位置：首页 SCI期刊 SCIE期刊医学中科院3区 JCRQ1 期刊介绍(非官网)

Expert Review Of Molecular DiagnosticsSCIE

国际简称：EXPERT REV MOL DIAGN 参考译名：分子诊断专家评论

中科院分区
3区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：1473-7159; E-ISSN：1744-8352; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：ENGLAND; 出版商：Taylor and Francis Ltd.; 出版语言：English; 出版周期：Bimonthly; 出版年份：2001; 研究方向：医学-病理学

评价信息：: 影响因子：3.9; H-index：68; CiteScore指数：6.6; SJR指数：0.823; SNIP指数：0.77

发文数据：: Gold OA文章占比：15.33%; 研究类文章占比：45.28%; 年发文量：106; 自引率：0; 开源占比：0.1115; 出版撤稿占比：0; 出版国人文章占比：0.09; OA被引用占比：0.0374...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Expert Review Of Molecular Diagnostics期刊介绍

Expert Review of Molecular Diagnostics (ISSN 1473-7159) publishes expert reviews of the latest advancements in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease that are being translated into groundbreaking diagnostic and prognostic technologies to be used in the clinical diagnostic setting.

Each issue of Expert Review of Molecular Diagnostics contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process; editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations featuring assessments of significant, recently published articles from specialists in molecular diagnostic therapy.

Expert Review of Molecular Diagnostics provides the forum for reporting the critical advances being made in this ever-expanding field, as well as the major challenges ahead in their clinical implementation. The journal delivers this information in concise, at-a-glance article formats: invaluable to a time-constrained community.

期刊简介Expert Review Of Molecular Diagnostics期刊介绍

《Expert Review Of Molecular Diagnostics》自2001出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：较慢,6-12周
医学
PATHOLOGY
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Expert Review Of Molecular Diagnostics Cite Score数据

CiteScore：6.6
SJR：0.823
SNIP：0.77

学科类别	分区	排名	百分位
大类：Medicine 小类：Pathology and Forensic Medicine	Q1	35 / 208	83%
大类：Medicine 小类：Genetics	Q2	113 / 347	67%
大类：Medicine 小类：Molecular Medicine	Q2	77 / 178	57%
大类：Medicine 小类：Molecular Biology	Q2	186 / 410	54%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Expert Review Of Molecular Diagnostics 中科院分区

中科院 2023年12月升级版 综述期刊：是 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	PATHOLOGY 病理学	3区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Expert Review Of Molecular Diagnostics JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PATHOLOGY	SCIE	Q1	17 / 88	81.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PATHOLOGY	SCIE	Q2	26 / 88	71.02%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA106
Italy54
CHINA MAINLAND41
Spain27
England26
GERMANY (FED REP GER)23
France19
Brazil13
Australia12
Denmark11

本刊中国学者近年发表论文

1、Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis
Author: Jiang, Lan; Sun, Ge; Zou, Lina; Guan, Yue; Hang, Yongzheng; Liu, Yanan; Zhou, Zhiren; Zhang, Xueqing; Huang, Xiaojing; Pan, Hongzhi; Rong, Shengzhong; Ma, Hongkun

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14737159.2023.2195554
2、Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features
Author: Chen, Yi; Liu, Xiaoling; Huang, Liyun; Chen, Lihong; Wang, Bin

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14737159.2023.2205588
3、Prognostic role and immune infiltration characteristics of EI24 in multiple cancer types
Author: Yang, Wanli; Zhou, Wei; Zhao, Xinhui; Duan, Lili; Niu, Liaoran; Zhang, Yujie; Li, Yiding; Wang, Xiaoqian; Chen, Junfeng; Fan, Aqiang; Xie, Qibin; Liu, Jinqiang; Han, Yu; Fan, Daiming; Hong, Liu

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14737159.2023.2206520
4、Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study
Author: Duan, Fujiao; Liu, Ling; Chen, Xiaolin; Yang, Qian; Wang, Yiran; Zhang, Yaodong; Wang, Kaijuan

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14737159.2023.2206957
5、CEMIP as a prognostic biomarker for cancers: a meta- and bioinformatic analysis
Author: Chen, Huan; Wang, Qingting; Liu, Jin; Chen, Yuqian; Zhang, Qianqian; Chai, Limin; Wang, Yan; Li, Danyang; Qiu, Yuanjie; Li, Manxiang

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. 22, Issue 12, pp. 1107-1115. DOI: 10.1080/14737159.2022.2168191
6、Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis
Author: Yinzhong, Wang; Miaomiao, Wang; Xiaoxue, Tian; Qian, Wang; Meng, Qi; Junqiang, Lei

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. 23, Issue 1, pp. 63-69. DOI: 10.1080/14737159.2023.2167555
7、Bacterial extracellular vesicles in biofluids as potential diagnostic biomarkers
Author: Su, Kar-Yan; Koh Kok, Jie-Yi; Chua, Yie-Wei; Ong, Shearn-Dior; Ser, Hooi Leng; Pusparajah, Priyia; San Saw, Pui; Goh, Bey Hing; Lee, Wai-Leng

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1080/14737159.2022.2166403
8、Evaluation of transcriptomic molecular classification, biological behavior, and clinicopathological features in hepatocellular carcinoma
Author: Chen, Ruonan; Zhou, Zixiong; Chen, Yi; Huang, Aimin; Chen, Lihong

Journal: EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2023; Vol. 23, Issue 1, pp. 71-84. DOI: 10.1080/14737159.2023.2169072